In a groundbreaking new study, researchers have discovered an early epigenetic gene-regulating mechanism that could be key to developing new treatments for blood cell-related diseases. The research, conducted by a team of scientists from the University of Toronto and funded by the Canadian Institutes of Health Research, examined how epigenetic gene-regulating enzymes, called histone methyltransferases, interact with the DNA in blood cells. They found that these enzymes regulate gene expression in a way that is distinct from how it is regulated in other cells. This new understanding of epigenetic regulation could have implications for the development of new treatments for blood cell-related diseases such as leukemia, anemia, and multiple myeloma.

Read Full Article Here

source: Phys.org